Lincoln Pharmaceuticals Share Price
₹771.70 -15 (-1.91%)
28 Dec, 2024 01:01
Start SIP in LINCOLN
Start SIPPerformance
- Low
- ₹762
- High
- ₹794
- 52 Week Low
- ₹535
- 52 Week High
- ₹980
- Open Price₹779
- Previous Close₹787
- Volume65,033
Investment Returns
- Over 1 Month + 22.79%
- Over 3 Month + 12.17%
- Over 6 Month + 26.09%
- Over 1 Year + 24.48%
Smart Investing Starts Here Start SIP with Lincoln Pharmaceuticals for Steady Growth!
Lincoln Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 16
- PEG Ratio
- 0.8
- Market Cap Cr
- 1,546
- P/B Ratio
- 2.6
- Average True Range
- 45.78
- EPS
- 48.25
- Dividend Yield
- 0.2
- MACD Signal
- 42.02
- RSI
- 44.46
- MFI
- 41.44
Lincoln Pharmaceuticals Financials
Lincoln Pharmaceuticals Technicals
EMA & SMA
Current Price
₹771.70
-15
(-1.91%)
- Bullish Moving Average 7
- Bearish Moving Average 9
- 20 Day
- ₹814.50
- 50 Day
- ₹763.46
- 100 Day
- ₹723.37
- 200 Day
- ₹677.54
Resistance and Support
776.03
- R3 821.42
- R2 807.73
- R1 789.72
- S1 758.02
- S2 744.33
- S3 726.32
Lincoln Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-14 | Quarterly Results | |
2024-08-08 | Quarterly Results | |
2024-05-16 | Audited Results & Final Dividend | |
2024-02-08 | Quarterly Results | |
2023-11-02 | Quarterly Results |
Lincoln Pharmaceuticals F&O
About Lincoln Pharmaceuticals
- NSE Symbol
- LINCOLN
- BSE Symbol
- 531633
- Managing Director
- Mr. Mahendra G Patel
- ISIN
- INE405C01035
Similar Stocks to Lincoln Pharmaceuticals
Lincoln Pharmaceuticals FAQs
Lincoln Pharmaceuticals share price is ₹771 As on 28 December, 2024 | 00:47
The Market Cap of Lincoln Pharmaceuticals is ₹1545.7 Cr As on 28 December, 2024 | 00:47
The P/E ratio of Lincoln Pharmaceuticals is 16 As on 28 December, 2024 | 00:47
The PB ratio of Lincoln Pharmaceuticals is 2.6 As on 28 December, 2024 | 00:47
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.